Colon cancer metastasis: is E2F-1 a driving force?
D000230:Adenocarcinoma / Q000235:genetics* / Q000473:pathology*; D018797:Cell Cycle Proteins / Q000096:biosynthesis* / Q000235:genetics* / Q000494:pharmacology; D002471:Cell Transformation, Neoplastic; D003110:Colonic Neoplasms / Q000235:genetics* / Q000473:pathology*; D004268:DNA-Binding Proteins / Q000096:biosynthesis* / Q000235:genetics* / Q000494:pharmacology; D018450:Disease Progression; D050684:E2F Transcription Factors; D050687:E2F1 Transcription Factor; D005784:Gene Amplification; D006801:Humans; D008113:Liver Neoplasms / Q000235:genetics* / Q000503:physiopathology / Q000556:secondary*; D008175:Lung Neoplasms / Q000235:genetics* / Q000503:physiopathology / Q000556:secondary*; D009362:Neoplasm Metastasis / Q000503:physiopathology; D013940:Thymidylate Synthase / Q000096:biosynthesis*; D014157:Transcription Factors / Q000096:biosynthesis* / Q000235:genetics* / Q000494:pharmacology
D018797:Cell Cycle Proteins; D004268:DNA-Binding Proteins; D050684:E2F Transcription Factors; D050687:E2F1 Transcription Factor; C493753:E2F1 protein, human; D014157:Transcription Factors; D013940:Thymidylate Synthase